Ginkgo Bioworks Announces Multi-Target RNA Discovery Collaboration with Pfizer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Ovintiv adds 41,000 acres in Permian and Montney deals
- Russia says it could strike UK military targets in response to Kyiv's use of British missiles
Ginkgo Bioworks (DNA) Climbs 11% Following Pact with Pfizer (PFE)
September 27, 2023 7:05 AM EDTGinkgo Bioworks (NYSE: DNA) Climbs 11% Following Pact with Pfizer (NYSE: PFE)
Ginkgo Bioworks (NYSE: DNA) today announced a collaboration with Pfizer (NYSE: PFE) focused on the discovery of RNA-based drug candidates.
